Abstract:Hypertension is the leading risk factor for global mortality and morbidity and those with hypertension are more likely to develop severe symptoms in cardiovascular and cerebrovascular system, which is closely related to abnormal renin-angiotensin system and elabela/apelin-apelin receptor (APJ) axis. The elabela/apelin-APJ axis exerts essential roles in regulating blood pressure levels, vascular tone, and cardiovascular dysfunction in hypertension by counterbalancing the action of the angiotensin II/angiotensin II type 1 receptor axis and enhancing the endothelial nitric oxide (NO) synthase/NO signaling. Furthermore, the elabela/apelin-APJ axis demonstrates beneficial effects in cardiovascular physiology and pathophysiology, including angiogenesis, cellular proliferation, fibrosis, apoptosis, oxidative stress, and cardiovascular remodeling and dysfunction during hypertension. More importantly, effects of the elabela/apelin-APJ axis on vascular tone may depend upon blood vessel type or various pathological conditions. Intriguingly, the broad distribution of elabela/apelin and alternative isoforms implicates its distinct functions in diverse cardiac and vascular cells and tissue types. Finally, both loss-of-function and gain-of-function approaches have defined critical roles of the elabela/apelin-APJ axis in reducing the development and severity of hypertensive diseases. Thus, targeting the elabela/apelin-APJ axis has emerged as a pre-warning biomarker and a novel therapeutic approach against progression of hypertension, and an increased understanding of cardiovascular actions of the elabela/apelin-APJ axis will help to develop effective interventions for hypertension. In this review, we focus on the physiology and biochemistry, diverse actions, and underlying mechanisms of the elabela/apelin-APJ axis, highlighting its role in hypertension and hypertensive cardiovascular injury and dysfunction, with a view to provide a prospective strategy for hypertensive disease therapy.

Implications for Obesity Hypertension

Highlights of mechanisms and treatment of obesity-related hypertension

Factors Responsible for Obesity-Related Hypertension

New developments in the pathogenesis of obesity-induced hypertension

Improving obesity and blood pressure

Assessment of Possible Role of Renin Angiotensin Aldosterone System in Obesity: Review Article

Central Nervous System Dysfunction in Obesity-Induced Hypertension

Weight Loss Therapies and Hypertension Benefits

Leptin-Induced Sympathetic Nerve Activation: Signaling Mechanisms and Cardiovascular Consequences in Obesity

Obesity-related hypertension and chronic kidney disease: from evaluation to management

Alternative Perspectives on Obesity and Hypertension

Obesity and cardiovascular health

Pathophysiology and treatment of obesity‐related hypertension

Obesity-Related Metabolic Syndrome: Mechanisms of Sympathetic Overactivity

The Role of the Autonomic Nervous System in the Pathophysiology of Obesity

Oxytocin and Vasopressin Systems in Obesity and Metabolic Health: Mechanisms and Perspectives

Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives

Angiotensin in the Arcuate: Mechanisms Integrating Cardiometabolic Control

Experimental and Clinical Evidence of Altered Interactions in Obesity and Diabetes Mellitus

Cardiovascular Disease Risk Reduction and Body Mass Index

Targeting the elabela/apelin–apelin receptor axis as a novel therapeutic approach for hypertension